Hairy Cell Leukemia Variant Clinical Trials in Bethesda, Maryland
2 recruitingBethesda, Maryland
Showing 1–2 of 2 trials
Recruiting
Phase 2
Venetoclax for the Treatment of Patients With Relapsed Hairy Cell Leukemia
Recurrent Hairy Cell LeukemiaRecurrent Hairy Cell Leukemia Variant
National Cancer Institute (NCI)20 enrolled21 locationsNCT06311227
Recruiting
Phase 1
Phase I Study of Anti-CD22 Chimeric Receptor T Cells in Patients With Relapsed/Refractory Hairy Cell Leukemia and Variant
Hairy Cell LeukemiaHairy Cell Leukemia Variant
National Cancer Institute (NCI)27 enrolled1 locationNCT04815356